Most people with ALS live three to five years after diagnosis. But that number is an average, and individual outcomes vary widely depending on age, where symptoms start, and the type of care received. About 20% of people live five years or more, 10% live beyond a decade, and roughly 5% survive 20 years or longer.
What the Average Survival Numbers Mean
The three-to-five-year figure you’ll see cited most often starts from the point of diagnosis, not from when symptoms first appeared. Since many people experience subtle symptoms for months or even a year before getting diagnosed, total time living with the disease is often longer than that window suggests.
It’s also worth understanding that “average” masks a wide distribution. Some people decline rapidly within a year or two, while others live for decades. Stephen Hawking, diagnosed at 21, lived more than 50 years with the disease. His case was extraordinary, but it illustrates that ALS doesn’t follow a single timeline.
Where Symptoms Start Matters
ALS typically begins in one of two ways. Spinal-onset ALS starts in the limbs, with weakness in the arms or legs. Bulbar-onset ALS starts in the muscles controlling speech and swallowing. Where it begins significantly affects how long a person lives.
People with spinal-onset ALS have a five-year survival rate between 37% and 44%, with an average disease duration of roughly two to three years. Those with bulbar-onset ALS face a shorter timeline: a five-year survival rate of only 9% to 14%, with average disease duration of one to two years. Bulbar-onset ALS tends to affect breathing muscles earlier, which is the primary driver of the shorter survival.
Age at Diagnosis Is a Strong Predictor
Younger people with ALS generally live longer. A study comparing patients diagnosed before age 40 to those diagnosed later found a striking difference: median survival was about 71 months (nearly six years) in the younger group, compared to 44 months (about three and a half years) in the older group. Among younger patients, 50% of those with predominantly upper motor neuron involvement survived at least five years, and about 18% lived beyond ten years.
The reasons aren’t entirely clear, but younger patients more often develop a slower-progressing form of the disease that primarily affects upper motor neurons. This subtype tends to cause stiffness and spasticity rather than rapid muscle wasting, and it follows a more gradual course.
How Care and Treatment Extend Survival
Where and how you receive care has a measurable impact on how long you live with ALS. People treated at specialized multidisciplinary ALS clinics, where neurologists, respiratory therapists, nutritionists, physical therapists, and other specialists work together, live significantly longer than those who see a general neurologist alone. One population-based study found that patients at multidisciplinary clinics had a median survival 7.5 months longer than those in general neurology care. The effect was even more pronounced for people with bulbar-onset ALS, whose median survival nearly doubled: 657 days at a specialized clinic versus 363 days in general care.
The clinic setting itself accounted for a 47% reduction in mortality risk, making it the single strongest factor in that study, larger than age, onset type, or other clinical variables. This isn’t because of any one treatment. It’s the cumulative effect of catching complications early, managing nutrition before weight loss becomes dangerous, and introducing breathing support at the right time.
Breathing Support
Respiratory failure is the most common cause of death in ALS, so breathing support plays a central role in survival. Non-invasive ventilation, a mask-based device that assists breathing (similar to a CPAP), extended median survival by about seven months in a randomized trial of ALS patients. It also maintained quality of life for most of that period. For people with severe bulbar involvement, the survival benefit was smaller, though it still helped with sleep-related breathing problems.
Some people eventually transition to invasive ventilation through a tracheostomy, which can sustain life for years or even decades. This is a significant decision that involves full-time mechanical breathing support and usually round-the-clock caregiving.
Nutrition
Weight loss and malnutrition accelerate decline in ALS. As swallowing becomes difficult, many people benefit from a feeding tube, which helps maintain caloric intake and hydration. Studies consistently show that maintaining body weight is associated with slower progression, making nutritional management one of the more practical factors within a person’s control.
The Role of ALS Subtype
Not all ALS behaves the same way, and doctors increasingly recognize distinct subtypes with different trajectories. Classic ALS, involving both upper and lower motor neurons with rapid progression, follows the typical three-to-five-year timeline. But variants exist that progress more slowly. Primary lateral sclerosis, which affects only upper motor neurons, can have a disease course spanning a decade or more. Progressive muscular atrophy, affecting primarily lower motor neurons, also tends to progress more slowly than classic ALS in many cases.
A small percentage of ALS cases, roughly 5% to 10%, are caused by inherited genetic mutations. One of these, involving the SOD1 gene, now has a targeted treatment approved by the FDA. This therapy was approved based on its ability to reduce a biomarker of nerve damage, though long-term survival data are still being collected. For the vast majority of ALS cases, which are not linked to a known gene, treatment focuses on slowing progression and managing symptoms rather than targeting a specific cause.
What Affects Quality of Life Along the Way
Survival time is one question, but many people searching this topic also want to understand what those years look like. ALS progresses through recognizable stages. Early on, a person may have weakness in one limb or difficulty with speech, but can still live independently. Over time, the disease spreads to other muscle groups. Most people eventually need assistance with daily activities like eating, dressing, and moving around.
Cognitive function is preserved in the majority of cases, meaning most people remain mentally sharp even as physical abilities decline. About 10% to 15% of people with ALS also develop frontotemporal dementia, which affects behavior and decision-making, but this is the exception rather than the rule. Communication devices, powered wheelchairs, and other adaptive technologies can help maintain independence and connection with others well into the disease course.
The combination of early specialized care, breathing support, nutritional management, and adaptive equipment doesn’t just add months. It shapes the quality of the time a person has. People who engage with multidisciplinary teams early tend to navigate transitions more smoothly and maintain function longer than those who wait until crises arise.